ATE240728T1 - Neue verbindungen nutlich als neuroschützende mittel - Google Patents
Neue verbindungen nutlich als neuroschützende mittelInfo
- Publication number
- ATE240728T1 ATE240728T1 AT97909975T AT97909975T ATE240728T1 AT E240728 T1 ATE240728 T1 AT E240728T1 AT 97909975 T AT97909975 T AT 97909975T AT 97909975 T AT97909975 T AT 97909975T AT E240728 T1 ATE240728 T1 AT E240728T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds useful
- new compounds
- neuroprotective agents
- agents
- neuroprotective
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/56—Benzoxazoles; Hydrogenated benzoxazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D263/57—Aryl or substituted aryl radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/24—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Adhesives Or Adhesive Processes (AREA)
- Liquid Crystal Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2756096P | 1996-10-07 | 1996-10-07 | |
PCT/US1997/017963 WO1998015274A1 (en) | 1996-10-07 | 1997-10-06 | Novel compounds useful as neuro-protective agents |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240728T1 true ATE240728T1 (de) | 2003-06-15 |
Family
ID=21838447
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97909975T ATE240728T1 (de) | 1996-10-07 | 1997-10-06 | Neue verbindungen nutlich als neuroschützende mittel |
Country Status (19)
Country | Link |
---|---|
US (4) | US6156748A (de) |
EP (1) | EP0971709B1 (de) |
CN (1) | CN1239889A (de) |
AT (1) | ATE240728T1 (de) |
AU (1) | AU721355B2 (de) |
CA (1) | CA2270661A1 (de) |
CZ (1) | CZ166399A3 (de) |
DE (1) | DE69722258T2 (de) |
DK (1) | DK0971709T3 (de) |
EA (1) | EA001713B1 (de) |
ES (1) | ES2199353T3 (de) |
HU (1) | HUP9904682A3 (de) |
ID (1) | ID21472A (de) |
IL (1) | IL129748A (de) |
NO (1) | NO313193B1 (de) |
NZ (1) | NZ335610A (de) |
PT (1) | PT971709E (de) |
TR (1) | TR199901559T2 (de) |
WO (1) | WO1998015274A1 (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0908180A3 (de) * | 1997-08-28 | 1999-04-21 | Eli Lilly And Company | Verwendung von Phenyloxazol oder Phenylthiazol Derivaten zur Behandlung von Schmerzen |
US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
TR200100352T2 (tr) * | 1997-10-06 | 2001-06-21 | Eli Lilly And Company | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler |
IT1300055B1 (it) * | 1998-04-17 | 2000-04-05 | Boehringer Ingelheim Italia | Eterocicli con anello a 5 termini difenil-sostituiti loro procedimento di preparazione e loro impiego come farmici |
EP1218336A2 (de) | 1999-09-20 | 2002-07-03 | Takeda Chemical Industries, Ltd. | Antagonisten des melanin-konzentrierenden hormons |
FR2812546B1 (fr) * | 2000-08-01 | 2008-11-21 | Sod Conseils Rech Applic | Derives d'heterocycles a 5 chainons, leur preparation et leur application a titre de medicaments |
TWI283577B (en) * | 1999-10-11 | 2007-07-11 | Sod Conseils Rech Applic | Pharmaceutical composition of imidazole derivatives acting as modulators of sodium channels and the use thereof |
EP1285651B1 (de) | 2000-04-28 | 2010-09-01 | Takeda Pharmaceutical Company Limited | Antagonisten des melanin-konzentrierenden hormons |
JP2004531479A (ja) * | 2001-02-08 | 2004-10-14 | カロ バイオ アクチェブラーグ | 甲状腺受容体リガンドとしてのフェノキシ置換されたベンゾ縮合ヘテロアリール誘導体 |
US7091357B2 (en) * | 2001-12-26 | 2006-08-15 | University Of Kentucky Research Foundation | Chain-modified pyridino-N substituted nicotine compounds for use in the treatment of CNS pathologies |
WO2004005267A2 (en) | 2002-07-03 | 2004-01-15 | Janssen Pharmaceutica, N.V. | Heteroaryl compounds useful in treating inflammatory disorders |
HUE027110T2 (en) | 2003-02-04 | 2016-08-29 | Cornell Res Foundation Inc | Use of an aromatic cationic peptide |
TW200505913A (en) | 2003-03-28 | 2005-02-16 | Hoffmann La Roche | Novel oxazole derivatives, their manufacture and use as pharmaceutical agents |
US7353897B2 (en) * | 2003-07-23 | 2008-04-08 | Fernandez Dennis S | Telematic method and apparatus with integrated power source |
CN1938042B (zh) | 2004-01-23 | 2010-06-02 | 科内尔研究基金会 | 芳香族阳离子肽在制备用于减轻氧化性损伤药物中的应用 |
USRE46792E1 (en) | 2005-11-15 | 2018-04-17 | Otsuka Pharmaceutical Co., Ltd. | Oxazole compound and pharmaceutical composition |
WO2012031719A1 (de) | 2010-09-06 | 2012-03-15 | Arys Gmbh | Betankbarer akku |
US10881162B2 (en) | 2015-05-07 | 2021-01-05 | Exero Labs LLC | Device for minimizing impact of collisions for a helmet |
WO2024040267A2 (en) * | 2022-08-19 | 2024-02-22 | Mitokinin, Inc. | Direct synthesis of n-(3-substituted-chroman-4-yl)-7h- pyrrolo[2,3-d]pyrimidin-4-amines and derivatives thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4636516A (en) * | 1981-02-19 | 1987-01-13 | Yamanouchi Pharmaceutical Co., Ltd. | 3,5-di-tert-butyl-4-hydroxyphenyl-substituted heterocyclic compounds |
DE3425118A1 (de) * | 1984-07-07 | 1986-01-16 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue redox-indikatoren |
GB8531608D0 (en) * | 1985-12-23 | 1986-02-05 | Beecham Group Plc | Treatment |
DE3621775A1 (de) * | 1986-03-13 | 1988-01-07 | Thomae Gmbh Dr K | Neue substituierte thiazole und oxazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung |
DE3903993A1 (de) * | 1989-02-10 | 1990-08-16 | Basf Ag | Diarylsubstituierte heterocyclische verbindungen, ihre herstellung und arzneimittel daraus |
CA2009470A1 (en) * | 1989-02-08 | 1990-08-08 | Yu Momose | Oxazole compounds and their use |
AU645867B2 (en) * | 1990-11-30 | 1994-01-27 | Teijin Pharma Limited | 2-arylthiazole derivative and pharmaceutical composition containing the same |
US5633271A (en) * | 1992-05-26 | 1997-05-27 | E. I. Du Pont De Nemours And Company | Arthropodicidal oxazolines and thiazolines |
DE4304197A1 (de) * | 1993-02-12 | 1994-08-18 | Bayer Ag | Substituierte Oxazole |
US5428048A (en) * | 1993-11-08 | 1995-06-27 | American Home Products Corporation | Aryl-N-hydroxyureas as inhibitors of 5-lipoxygenase and anto-arteriosclerotic agents |
US6251928B1 (en) * | 1994-03-16 | 2001-06-26 | Eli Lilly And Company | Treatment of alzheimer's disease employing inhibitors of cathepsin D |
US5942530A (en) * | 1997-08-28 | 1999-08-24 | Eli Lilly And Company | Method for treating pain |
US5952360A (en) * | 1997-08-28 | 1999-09-14 | Eli Lilly And Company | Method for treating neuropathic pain |
EP0908180A3 (de) * | 1997-08-28 | 1999-04-21 | Eli Lilly And Company | Verwendung von Phenyloxazol oder Phenylthiazol Derivaten zur Behandlung von Schmerzen |
TR200100352T2 (tr) * | 1997-10-06 | 2001-06-21 | Eli Lilly And Company | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler |
-
1997
- 1997-10-06 AT AT97909975T patent/ATE240728T1/de not_active IP Right Cessation
- 1997-10-06 US US08/944,468 patent/US6156748A/en not_active Expired - Fee Related
- 1997-10-06 EA EA199900362A patent/EA001713B1/ru not_active IP Right Cessation
- 1997-10-06 CN CN97180378A patent/CN1239889A/zh active Pending
- 1997-10-06 TR TR1999/01559T patent/TR199901559T2/xx unknown
- 1997-10-06 ES ES97909975T patent/ES2199353T3/es not_active Expired - Lifetime
- 1997-10-06 DE DE69722258T patent/DE69722258T2/de not_active Expired - Fee Related
- 1997-10-06 WO PCT/US1997/017963 patent/WO1998015274A1/en not_active Application Discontinuation
- 1997-10-06 PT PT97909975T patent/PT971709E/pt unknown
- 1997-10-06 DK DK97909975T patent/DK0971709T3/da active
- 1997-10-06 IL IL12974897A patent/IL129748A/xx not_active IP Right Cessation
- 1997-10-06 HU HU9904682A patent/HUP9904682A3/hu unknown
- 1997-10-06 AU AU47459/97A patent/AU721355B2/en not_active Ceased
- 1997-10-06 ID IDW990301A patent/ID21472A/id unknown
- 1997-10-06 NZ NZ335610A patent/NZ335610A/xx unknown
- 1997-10-06 CA CA002270661A patent/CA2270661A1/en not_active Abandoned
- 1997-10-06 CZ CZ991663A patent/CZ166399A3/cs unknown
- 1997-10-06 EP EP97909975A patent/EP0971709B1/de not_active Expired - Lifetime
-
1999
- 1999-05-07 NO NO19992226A patent/NO313193B1/no not_active IP Right Cessation
- 1999-08-04 US US09/368,236 patent/US6166216A/en not_active Expired - Fee Related
-
2000
- 2000-11-17 US US09/715,987 patent/US6380213B1/en not_active Expired - Fee Related
-
2001
- 2001-11-28 US US09/996,005 patent/US6423709B1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2270661A1 (en) | 1998-04-16 |
EP0971709A4 (de) | 2001-04-11 |
CZ166399A3 (cs) | 1999-11-17 |
DE69722258T2 (de) | 2004-03-18 |
IL129748A0 (en) | 2000-02-29 |
EP0971709A1 (de) | 2000-01-19 |
HUP9904682A3 (en) | 2001-09-28 |
US6166216A (en) | 2000-12-26 |
NO992226L (no) | 1999-05-27 |
EA001713B1 (ru) | 2001-08-27 |
DE69722258D1 (de) | 2003-06-26 |
NZ335610A (en) | 2000-10-27 |
US20020065274A1 (en) | 2002-05-30 |
EA199900362A1 (ru) | 2000-02-28 |
AU721355B2 (en) | 2000-06-29 |
US6156748A (en) | 2000-12-05 |
US6423709B1 (en) | 2002-07-23 |
US6380213B1 (en) | 2002-04-30 |
ID21472A (id) | 1999-06-17 |
AU4745997A (en) | 1998-05-05 |
HUP9904682A2 (hu) | 2000-05-28 |
NO313193B1 (no) | 2002-08-26 |
TR199901559T2 (xx) | 1999-09-21 |
PT971709E (pt) | 2003-09-30 |
EP0971709B1 (de) | 2003-05-21 |
DK0971709T3 (da) | 2003-09-22 |
WO1998015274A1 (en) | 1998-04-16 |
CN1239889A (zh) | 1999-12-29 |
IL129748A (en) | 2003-11-23 |
ES2199353T3 (es) | 2004-02-16 |
NO992226D0 (no) | 1999-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE240728T1 (de) | Neue verbindungen nutlich als neuroschützende mittel | |
DE69821633D1 (de) | Heterozyklische verbindungen und antitumormittel, das diese als aktiven wirkstoff enthält | |
TR199800679T2 (xx) | Kiral metil fenil oksazolidinon. | |
BR0013493B1 (pt) | derivado de oxazol, composição farmacêutica, composto, e, uso de um derivado de oxazol ou um sal do mesmo | |
ATE264313T1 (de) | Substituierte oxazole und thiazole derivate als hppar-gamma und hppar-alpha aktivatore | |
ATE265442T1 (de) | Substituierte oxazole und thiazole derivate als hppar-alpha aktivatore | |
DK0699192T3 (da) | Substituerede oxazolylforbindelser til behandling af inflammation | |
ATE293611T1 (de) | Thiazol und oxazol-derivate als aktivatoren von menschlichen peroxisom proliferator aktivierten rezeptoren | |
DE59913784D1 (de) | Verwendung von Thiazolidinderivaten als antihyperglykämische Mittel | |
HUP9801201A2 (hu) | Taxoidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények | |
TR200103612T2 (tr) | Tiazol ve oksazol türevleri ve farmasötik kullanımları | |
TR199901653T2 (xx) | Fitalazinonlar. | |
DE60024414D1 (de) | Oxadiazolverbindungen und -zusammensetzungen zur abgabe von wirkstoffen | |
BR9804865A (pt) | Pesticida 3-(fenil substitu¡do)-5-(tirnil ou furil)-1,2,4-triazÄis | |
DE59702414D1 (de) | Dipeptidische benzamidine als kininogenasen-inhibitoren | |
DE69602970D1 (de) | 5-(phenyl)-3-(4-piperidinyl)-1,3,4-oxadiazol-2(3h)-on-derivate verwendbar als 5-ht4- oder h3-rezeptorliganden | |
ATE246189T1 (de) | Bizyklische oxazolidinone als antibakterielle mittel | |
TR200100352T2 (tr) | Nöro-koruyucu maddeler olarak yararlı yeni bileşikler | |
DK1301207T3 (da) | Sammensætninger til behandling af bakterieinfektioner indeholdende en oxazolidinonforbindelse, sulbactam og ampicillin | |
RS50136B (sr) | Derivati tiazolidindiona i njihova upotreba kao antidijabetika | |
EP0270482A3 (en) | Use of 5-(substituted phenyl-)oxazolidinones in the treatment of depressions | |
TR200103240T2 (tr) | Endoparazit öldürücü bileşimler. | |
NO954892L (no) | Heterosyklisk kjemi | |
ATE329913T1 (de) | Oxazole als mglur1 verstärker | |
DK1032386T3 (da) | Anvendelse af oxazolidinonderivater til behandling af arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 0971709 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |